drugset / Trial / NCT06057675
Tranexamic Acid in Nasal Mohs Reconstruction
RandomizedParallel-groupDouble-blindPrevention
Summary
This study will be a prospective randomized control trial to evaluate the effects of subcutaneously administered TXA among patients undergoing nasal Mohs reconstruction with local flaps at VUMC.
Timeline
- Start
- 2024-03-19
- Primary completion
- 2026-06
- Completion
- 2026-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tranexamic Acid | Small molecule | 1 g | Subcutaneous |
| Background | Epinephrine | Other / unclassified | — | Subcutaneous |
| Background | Lidocaine | Other / unclassified | 1 % | Subcutaneous |